AstraZeneca
The Regulatory Affairs Director at AstraZeneca will lead US regulatory strategy for oncology programs, overseeing submissions, agency interactions, and cross‑functional teams to accelerate approvals and product labeling. The role involves strategic leadership, risk assessment, and collaboration with global stakeholders to bring innovative cancer therapies to patients.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
VP/SVP, Head of Regulatory Affairs
Systimmune
Director, Regulatory Affairs
Revolution Medicines
Associate Director, Regulatory Affairs CMC
Olema Oncology
Associate Director Regulatory Affairs, Oncology
GSK plc
Manager, Regulatory Affairs
Regeneron Pharmaceuticals
Manager, Global Regulatory Affairs, Oncology
GSK plc